These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23091085)

  • 1. New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII).
    Rokita AG; Anderson ME
    Circulation; 2012 Oct; 126(17):2125-39. PubMed ID: 23091085
    [No Abstract]   [Full Text] [Related]  

  • 2. CaMKII as a target for arrhythmia suppression.
    Mustroph J; Neef S; Maier LS
    Pharmacol Ther; 2017 Aug; 176():22-31. PubMed ID: 27742568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of SR Ca
    Neef S; Mann C; Zwenger A; Dybkova N; Maier LS
    Basic Res Cardiol; 2017 Jul; 112(4):45. PubMed ID: 28612156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-calmodulin dependent protein kinase II (CaMKII): a main signal responsible for early reperfusion arrhythmias.
    Said M; Becerra R; Valverde CA; Kaetzel MA; Dedman JR; Mundiña-Weilenmann C; Wehrens XH; Vittone L; Mattiazzi A
    J Mol Cell Cardiol; 2011 Dec; 51(6):936-44. PubMed ID: 21888910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure.
    Sag CM; Wadsack DP; Khabbazzadeh S; Abesser M; Grefe C; Neumann K; Opiela MK; Backs J; Olson EN; Brown JH; Neef S; Maier SK; Maier LS
    Circ Heart Fail; 2009 Nov; 2(6):664-75. PubMed ID: 19919992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ca-calmodulin dependent kinase II: a promising target for future antiarrhythmic therapies?
    Fischer TH; Neef S; Maier LS
    J Mol Cell Cardiol; 2013 May; 58():182-7. PubMed ID: 23159442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias.
    Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac CaMKIIδ splice variants exhibit target signaling specificity and confer sex-selective arrhythmogenic actions in the ischemic-reperfused heart.
    Bell JR; Raaijmakers AJ; Curl CL; Reichelt ME; Harding TW; Bei A; Ng DC; Erickson JR; Vila Petroff M; Harrap SB; Delbridge LM
    Int J Cardiol; 2015 Feb; 181():288-96. PubMed ID: 25539453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental antiarrhythmic targets: CaMKII inhibition - ready for clinical evaluation?
    Maier LS
    Curr Med Chem; 2014; 21(11):1299-307. PubMed ID: 23862619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CaMKII in cardiac arrhythmias.
    Hund TJ; Mohler PJ
    Trends Cardiovasc Med; 2015 Jul; 25(5):392-7. PubMed ID: 25577293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac calmodulin kinase: a potential target for drug design.
    Bányász T; Szentandrássy N; Tóth A; Nánási PP; Magyar J; Chen-Izu Y
    Curr Med Chem; 2011; 18(24):3707-13. PubMed ID: 21774758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy.
    Khoo MS; Li J; Singh MV; Yang Y; Kannankeril P; Wu Y; Grueter CE; Guan X; Oddis CV; Zhang R; Mendes L; Ni G; Madu EC; Yang J; Bass M; Gomez RJ; Wadzinski BE; Olson EN; Colbran RJ; Anderson ME
    Circulation; 2006 Sep; 114(13):1352-9. PubMed ID: 16982937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CaMKII-dependent late Na
    Howard T; Greer-Short A; Satroplus T; Patel N; Nassal D; Mohler PJ; Hund TJ
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H794-H801. PubMed ID: 29932771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.
    Valverde CA; Mazzocchi G; Di Carlo MN; Ciocci Pardo A; Salas N; Ragone MI; Felice JI; Cely-Ortiz A; Consolini AE; Portiansky E; Mosca S; Kranias EG; Wehrens XHT; Mattiazzi A
    Cardiovasc Res; 2019 Mar; 115(3):556-569. PubMed ID: 30169578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2+/calmodulin-dependent protein kinase inhibition suppresses post-ischemic arrhythmogenesis and mediates sinus bradycardic recovery in reperfusion.
    Bell JR; Curl CL; Ip WT; Delbridge LM
    Int J Cardiol; 2012 Aug; 159(2):112-8. PubMed ID: 21392835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple downstream proarrhythmic targets for calmodulin kinase II: moving beyond an ion channel-centric focus.
    Anderson ME
    Cardiovasc Res; 2007 Mar; 73(4):657-66. PubMed ID: 17254559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias.
    Anderson ME
    Pharmacol Ther; 2005 Apr; 106(1):39-55. PubMed ID: 15781121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ryanodine receptor phosphorylation, calcium/calmodulin-dependent protein kinase II, and life-threatening ventricular arrhythmias.
    McCauley MD; Wehrens XH
    Trends Cardiovasc Med; 2011 Feb; 21(2):48-51. PubMed ID: 22578240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calm down when the heart is stressed: Inhibiting calmodulin-dependent protein kinase II for antiarrhythmias.
    Duan DD
    Trends Cardiovasc Med; 2015 Jul; 25(5):398-400. PubMed ID: 25910598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin kinase II inhibition limits the pro-arrhythmic Ca2+ waves induced by cAMP-phosphodiesterase inhibitors.
    Bobin P; Varin A; Lefebvre F; Fischmeister R; Vandecasteele G; Leroy J
    Cardiovasc Res; 2016 May; 110(1):151-61. PubMed ID: 26851245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.